Toth Financial Advisory’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$295 Buy
+5
New +$305 ﹤0.01% 1008

Other funds holding TVTX

Toth Financial Advisory's TVTX Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 5 shares worth $295. The stake represents ﹤0.01% of the portfolio and ranks #1008 among its holdings.

345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Toth Financial Advisory held 5 shares of Travere Therapeutics worth $295 as of Q3 2026.
  • Travere Therapeutics was a new Toth Financial Advisory position in Q3 2026.
  • Travere Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #1008 holding.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.